MedPath

A randomized, multicentril, open label, comparative efficacy study in healthy child.

Phase 3
Registration Number
CTRI/2022/01/039575
Lead Sponsor
Zydus Wellness Products Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Male or Female child between 6 years to 18 years of age.

2. Parents providing written informed consent and are willing to participate in the study.

3. Providing accent for trial (if participant age >11 years of age)

4. Parent agrees to provide milk/product as instructed.

5. No any active sign/symptom of illness, disease or disorder or any co morbidities such as IDDM as evaluated by Physician.

Exclusion Criteria

1. Child who has hypersensitivity to any drug or food product or nutritional product or Ayurvedic product.

2. Child taking medicine for any disease or disorder.

3. Child diagnosed with clinical disease or disorder including malnutrition or anemia which require therapeutic treatment.

4. Child with history of surgery within last 3 months of participation.

5. Child participated in any other clinical trial within last 3 months.

6. Investigator opinion on any foreseen subject non-compliances towards study protocol during the study execution.

7. Child height or weight is less than 13 percentile as per Indian Khadilkar Growth Chart.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- Event of Illness (infection and allergies) in the duration of the study.Timepoint: - 3 month <br/ ><br>- 6 month
Secondary Outcome Measures
NameTimeMethod
Average duration of illnessTimepoint: - 3 month <br/ ><br>- 6 month;Comparison of Laboratory parameter after illness resolvedTimepoint: - 6 month;Evaluation of physical strength/energy levelTimepoint: - 3 month <br/ ><br>- 6 month;Measurement of Anthropometric parameters (height and Weight) at baseline and end of studyTimepoint: - 6 month;Measurement of BMI at baseline and end of studyTimepoint: - 6 month;No of absent days due to illnessTimepoint: - 3 month <br/ ><br>- 6 month;Number of children having illnessTimepoint: - 3 month <br/ ><br>- 6 month;Number of days with reduced physical activityTimepoint: - 3 month <br/ ><br>- 6 month;Number of treatment daysTimepoint: - 3 month <br/ ><br>- 6 month;Severity of illnessTimepoint: - 3 month <br/ ><br>- 6 month;Total days of illness in a groupTimepoint: - 3 month <br/ ><br>- 6 month
© Copyright 2025. All Rights Reserved by MedPath